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Anxiety helps us anticipate and assess potential
danger in ambiguous situations [1–3]; however, the
anxiety disorders are the most prevalent class of
psychiatric illness [4–6]. Emotional states are shared
between humans and other animals [7], as observed
by behavioral manifestations [8], physiological re-
sponses [9], and gene conservation [10]. Anxiety
research makes wide use of three rodent behavioral
assays—elevated plus maze, open field, and light/
dark box—that present a choice between sheltered
and exposed regions [11]. Exposure avoidance in
anxiety-related defense behaviors was confirmed to
be a correlate of rodent anxiety by treatment with
known anxiety-altering agents [12–14] and is now
used to characterize anxiety systems. Modeling anx-
iety with a small neurogenetic animal would further
aid the elucidation of its neuronal and molecular ba-
ses. Drosophila neurogenetics research has eluci-
dated the mechanisms of fundamental behaviors
and implicated genes that are often orthologous
across species. In an enclosed arena, flies stay close
to the walls during spontaneous locomotion [15, 16],
a behavior proposed to be related to anxiety [17]. We
tested this hypothesis with manipulations of the
GABA receptor, serotonin signaling, and stress. The
effects of these interventions were strikingly concor-
dant with rodent anxiety, verifying that these behav-
iors report on an anxiety-like state. Application of this
method was able to identify several new fly anxiety
genes. The presence of conserved neurogenetic
pathways in the insect brain identifies Drosophila
as an attractive geneticmodel for the study of anxiety
and anxiety-related disorders, complementing exist-
ing rodent systems.
RESULTS
Flies Follow the Walls of an Enclosed Chamber
Flies in enclosed chambers spent a large proportion of time near
thewalls (Figures 1 and S1) [18, 19].While flies were able to crawlThis is an open access article undon all surfaces—floor, walls, and ceiling (Figure 1A)—cumulative
locomotion traces were strikingly similar to rodent thigmotaxis
data from open fields (Figure 1B) [14]. Flies on all surfaces
were close to the wall, often 3–4 mm away from the center of a
5-mm chamber (Figure S1C). This behavioral feature, but not
locomotion itself, was persistent (Figures S1D–S1F). We termed
this behavior ‘‘wall following’’ (WAFO).
Diazepam Reduces Fly Wall Following
Benzodiazepines reduce anxiety by modulating GABAA recep-
tors [20], and their binding site is evolutionarily conserved [21].
Diazepam reduces anxiety in three important rodent defense
behavior assays: the open field (OF), the elevated plus maze
(EPM), and the light/dark box [11]. In flies, diazepam had a
pronounced effect on fly WAFO at three doses (Figure 1C).
Raw behavioral metrics may have an indirect relationship
to internal state and are not comparable across diverse
experimental systems, for example, between different assays
in distinct species. To contextualize the diazepam result, we
calculated a standardized effect size (Hedges’ g) from the
diazepam-induced WAFO change (Figure 1C, lower panel)
and compared it with a meta-analytic rodent anxiety diazepam
effect size calculated from 382 published rodent experiments
(http://dx.doi.org/10.1101/020701). Diazepam effect sizes in
both systems were comparable (Figure 1D).
Altering d5-HT1B Function Has WAFO Effects that Are
Concordant with Mouse Anxiety
Genetic experiments in mouse previously demonstrated that
deleting and overexpressing the gene for the mammalian
5-HT1A receptor (m5-HT1A) produced moderate effects on
rodent anxiety (http://dx.doi.org/10.1101/020701). Drosophila
has two serotonin class 1 receptor genes with similarity to
m5-HT1A: d5-HT1A and d5-HT1B. The function of these
genes was knocked down in adult flies with lines expressing
RNAi under the control of a warm-induced pan-neuronal
driver, nSyb-Gal4, tub-Gal80ts [22, 23]. Alterations of d5-
HT1A expression with two RNAi lines and one cDNA
responder produced only minor changes in WAFO (Figure 2A).
However, the use of RNAi and overexpression to alter levels of
d5-HT1B produced pronounced effects on WAFO (Figure 2B).
These d5-HT1B effect sizes were of a comparable magnitude
to the mouse anxiety effects from m5-HT1A lesions (Figure 2D)
(http://dx.doi.org/10.1101/020701). Control experiments with
warm treatment of control flies had trivial WAFO effectsCurrent Biology 26, 981–986, April 4, 2016 ª2016 The Authors 981
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Figure 1. Drosophila Wall Following
Behavior Is Reduced by Diazepam
(A) Flies in a glass-topped arena walk on all interior
surfaces.
(B) Tracking data from a 10-min experiment reveal
that flies mainly walk in the perimeter of the arena.
(C) Flies fed with diazepam had decreased WAFO
compared with controls (g1 = 0.32, g2 = 8.0,
g3 =0.67, g4 =0.83, n = 40, 40). Fly WAFOwas
measured as mean distance from center in milli-
meters. Dots indicate the mean distance from
center for individual flies; horizontal line indicates
the mean distance from center (mm). p values
determined by Mann-Whitney U. The lower axis
represents the effect size in Hedges’ g with 95%
CI. Green circles and asterisk (*) mark a statistically
significant (p < 0.05) decrease in behavior.
(D) Standardized mean effect sizes of diazepam
effects on rodent anxiety (0.85 g [95 CI 0.74,
0.96]) and fly WAFO (0.83 g [95 CI 0.42,
0.91]) have comparable magnitudes.
See also Figure S1.(Figures 2A and 2B). We conclude that manipulating d5-HT1B
function influences fly WAFO in ways that parallel the ef-
fects that altering m5-HT1A expression has on mouse defense
behaviors.
Concordant SERT Effects on Fly WAFO and Mouse
Anxiety
Deletion ofmSert produces an increase in mouse anxiety (http://
dx.doi.org/10.1101/020701). In flies, reducing dSerT mRNA
levelswith either of twoRNAi alleles increasedWAFO (Figure 2C).
Flies expressing transgenic dSerT at 123 elevated levels (Fig-
ure S2P) had lowered WAFO (g = 0.53; Figure 2E), echoing
the low anxiety observed in mice expressing elevated mSert
(http://dx.doi.org/10.1101/020701). Control, warm-treated flies
underwent no WAFO change (Figure 2C).
Concordant Stress Effects on Fly WAFO and Mouse
Anxiety
Environmental stress drives anxiety [24]. Subjecting flies to heat
shock stress elicited a large WAFO increase (Figure 3A), concor-
dant with the effect of acute pain on rodent anxiety (Figure S3D)
([25]; http://dx.doi.org/10.1101/020701). Diazepam reduced982 Current Biology 26, 981–986, April 4, 2016WAFO in heat-stressed flies, much as it
did for flies at 25C (Figures S2Q and
S2R). Physically restraining flies pro-
duced aWAFO increase that was concor-
dant with the anxiogenic effect of restraint
in rodents (Figure S2E) (http://dx.doi.org/
10.1101/020701). Ten days of social
isolation stress increased fly WAFO (Fig-
ure S2F), an outcome that is concordant
with isolation’s effect on rodent anxiety
(http://dx.doi.org/10.1101/020701). The
corticotropin-releasing hormone receptor
1 (CRHR1) is associated with mammalian
stress, and knockout mice have lower
anxiety; the fly homolog is the diuretichormone 44 receptor 1 (DH44-R1) [26, 27]. Reducing Dh44-R1
expression (Figure S2O) reducedWAFO (Figure S2K), consistent
with mouse data (http://dx.doi.org/10.1101/020701). Interest-
ingly, Dh44-R1 mRNA levels were dramatically altered by all
three stressors (Figure S4D).
Anxiotropic Manipulations Influence Drosophila Light/
Dark Choice
A second fly shelter/exposure assay with anxiety concordance
would verify that exposure avoidance correlates with fly anxiety.
The rodent light/dark choice assay examines light avoidance
[12]. We used a simple chamber (Figure S3A) to measure
changes in fly light/dark choice in response to anxiety manipula-
tions. Of nine interventions, six (diazepam, d5-HT1B loss of func-
tion, dSerT overexpression, heat, restraint, and social isolation)
had substantial statistical effects that were concordant with ro-
dent anxiety data (Figure S3H). The other three were also direc-
tionally concordant but had modest, non-statistically significant
effects on light/dark choice (d5-HT1B overexpression, dSerT
knockdown, andDh44-R1 knockdown). These data largely verify
the hypothesis that exposure avoidance measures a fly anxiety
state.
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Figure 2. Anxiety-Concordant Effects of Se-
rotonin Gene Lesions on Fly WAFO
(A) Genetic lesions of d5-HT1A produced only
minor effects in WAFO. Blue dots are untreated
flies; orange dots are pre-warmed to 31C as
for GAL80ts derepression. The lower axes show
Hedges’ g; responder alleles are named in the
boxes. The driver is nSyb-Gal4, Tub-Gal80ts.
(B) Genetic lesions of d5-HT1B had moderate
and statistically significant effects on WAFO:
knockdown caused increases (d5-HT1BKK112342
g = 0.51, p = 9 3 103; d5-HT1BKK115609 g = 0.58,
p = 2 3 103), while overexpression elicited a
decrease (g = 0.82, p = 7.4 3 105, n = 53, 54).
Red and green circles indicate a statistically sig-
nificant WAFO change.
(C) Knockdowns of mSerT with two RNAi lines
produced consistent WAFO increases (SerTGD3824
g = 0.63, p = 8.2 3 104, n = 60, 55; SerTKK108310
g2 = 0.48, p = 0.2 3 102, n = 60, 40), and over-
expression decreased WAFO (dSerTSceryUAS$cPa
g = 0.53, p = 1.8 3 103, n = 73, 75). Warm-
treated controls for d5-HT1A, d5-HT1B, and
mSerT UAS transgenes underwent modest, non-
statistically significant changes.
(D) A comparison of mouse anxiety gene effect
sizes and fly ortholog WAFO effect sizes indicates
they are concordant in direction and magnitude,
except for d5-HT1A knockdowns. Diamonds
indicate averaged meta-analytic values; circles
indicate fly WAFO effect; lateral vertices and error
lines are 95% CI.
See also Figure S2.Effects in DrosophilaWAFO and Light/Dark Choice Are
Predictive of Rodent Anxiety Effects
Fly and rodent effect sizes for all interventions were subjected
to cross-species linear regression. The regression models
indicated that fly DWAFO data are largely predictive of rodent
anxiety changes (R2adj = 0.77 95% confidence interval [95 CI
0.47, 0.75]), as are the fly Dlight/dark choice outcomes
(R2adj = 0.81 [95 CI 0.58, 0.82]; Figures 3A and 3D). These
results are compatible with the hypothesis that fly WAFO and
fly light/dark choice, like rodent anxiety assays, test an anxi-
ety-related brain state.
Fly Defense Behaviors Are Distinct from Motor Activity
Motor activity and anxiety behavior are related phenotypes.
Tranquilizers like diazepam also have sedative effects, and
such overlap might also apply to neurogenetic systems. If
WAFO and/or light/dark choice changes were purely a result of
speed changes, this would erode confidence in their specificity
to anxiety. However, this was not the case. Walking speed was
altered in ways that were dissociated from WAFO (Figures
S1F, S2A–S2C, and S2H–S2K). Individual flies’ WAFO metrics
were poorly correlated with ‘‘raw’’ walking speed (WAFO-
locomotion R2adj = 0.18 [95 CI 0.17, 0.19], p = 1.0 3 10
91,
n = 2,046), as were their light/dark preferences (shade prefer-
ence-locomotion R2adj = 0.05 [95 CI 0.04, 0.06], p = 1.0 3
1013, n = 1,138). Additional regression analyses of fly walking
speed changes (Dspeed) indicated that these could explain
less than four-tenths of WAFO change variance (DWAFO; Fig-
ure 3C) and only a tenth of Dlight/dark variance (Figure 3F).Cross-species analyses indicated that fly speed changes were
weakly predictive of rodent anxiety: only a fifth (WAFO; Figure 3B)
and 6% (light/dark; Figure 3E) of variance was explained. Thus,
while locomotor changes contribute to DWAFO and Dlight/dark
choice, they are not the main driver.
Identification of 5-HT2B, tsr, tmod, CCKLR-17D1, and
CCKLR-17D3 as Fly Anxiety Factors
Wall following assays were used to identify fly anxiety gene can-
didates. Systematic review found that serotonin class 2 recep-
tor knockouts have not been tested for their mouse anxiety
role (http://dx.doi.org/10.1101/020701). Functional alterations
of the two fly class 2 receptor genes, d5-HT2A and d5-HT2B,
found that only the latter had consistent, substantial effects on
WAFO (Figure 4B). Fly orthologs of candidate anxiety genes
found at quantitative trait loci (QTLs) identified from a mouse ge-
netic experiment were screened [28]. Of 17 genes, four showed
WAFO alterations: twinstar (tsr), two Cholecystokinin-like recep-
tor genes (CCKLR-17D3 and CCKLR-17D1), and tropomodulin
(tmod) (Figure 4), which are homologs of mouse cofilin 1 (Cfl1),
cholecystokinin B receptor (Cckbr), and Tropomodulin-2
(Tmod2), respectively. Control tests of 17 randomly selected or-
thologs found none produced WAFO effects (Figure 4D). Inter-
estingly, two mouse orthologs of the four fly anxiety candidate
genes are known to anxiety research. Cofilin-1 is a mouse anxi-
ety gene with a knockout having a concordant outcome to the fly
WAFO result [28]. MouseCckbr codes for cholecystokinin recep-
tor, and its deletion has an effect concordant with knockdown
effects of fly WAFO [29].Current Biology 26, 981–986, April 4, 2016 983
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Figure 3. Fly Defense Behavior Outcomes Are Concordant with Anxiety Outcomes
(A) A strong correlation between rodent anxiety and fly WAFO data for nine comparable manipulations (R2adj = 0.77 [95 CI 0.58, 0.83]). The horizontal axis shows
rodent meta-analytic g values; the vertical axis displays fly WAFO g values. The red line is the least-squares fit; p is for the F statistic of the model.
(B) Walking speed changes in the square arena are weakly correlated with rodent anxiety outcomes (R2adj = 0.22 [95 CI 0.0, 0.30]).
(C) WAFO is moderately related to locomotion in the square arena (R2adj = 0.38 [95 CI 0.06, 0.49]).
(D) Light/dark choice outcomes are strongly correlated with rodent effect sizes (R2adj = 0.81 [95 CI 0.64, 0.86]).
(E) Changes in locomotion in the light/dark arena are weakly correlated with rodent anxiety outcomes (R2adj = 0.06 [95 CI 0.0, 0.09]).
(F) Light/dark choice outcomes are poorly correlated with locomotion (R2adj = 0.11 [95 CI 0.0, 0.14]).
See also Figure S3.DISCUSSION
The results verify the hypothesis that exposure avoidance behav-
iors of Drosophila share underlying neurogenetic pathways with
mammalian anxiety. A GABA-modulating drug, serotonin recep-
tor and transporter alterations, a stress peptide receptor, and
environmental stressors produced effects that were concordant
with comparable manipulations in mammalian anxiety-related
behaviors. A regression comparison of fly behavior data and
rodent anxiety data indicated that the two are similar. The high
coefficients of determination observed in the interspecies com-
parisons are remarkable in that they would not be expected to
account for sources of variance that include sampling error,
within- and between-lab heterogeneity, publication bias, >600
million years of evolutionary divergence, or the difference be-
tween semi-acute knockdowns and lifelong knockouts.
A candidate survey newly implicated d5-HT2B, tsr, tmod,
CCKLR-17D3, and CCKLR-17D1 in fly anxiety. The anxiolytic ef-
fect of tsr supports the hypothesis that actinmicrofilament stabil-
ity is connected to anxiety [28], consistent with ideas that actin
polymerization influences anxiety via aversive memory formation
and stability [30] and/or related processes [31]. Similarly, that984 Current Biology 26, 981–986, April 4, 2016CCK-like receptor knockdowns reduce fly anxiety supports the
hypothesis that CCK receptors are involved in anxiety and fear
[32, 33], with a role proposed specifically for the mammalian
cholecystokinin B receptor (CCKBR) [29]. In flies, the putative
ligand for the CCKLR receptors is DROSULFAKININ (DSK);
intriguingly, CCKLR-17D1 and dsk mutants have deficits in a
larval stress-induced escape behavior [34]. The implication of
CCK-like receptors in fly defense behaviors suggests that this
is an anxiety-related signaling system, like GABA, serotonin,
and Dh44-R1/CRHR1. Most of the orthologous gene knock-
downs produced no WAFO effect, suggesting that the QTL hits
include false positives and that WAFO genes are relatively rare.
Anxiety research has struggled to find new therapeutics [11].
Bringing the neurogenetic tools and larger sample sizes of
Drosophila to bear on anxiety promises to complement rodent
model analysis of anxiety and anxiety disorders.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.cub.2016.02.031.
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Figure 4. Identification of Candidate Fly
Anxiety Genes
(A) RNAi knockdown with d5-HT2AKK110704
increased WAFO (g = 0.48, p = 1 3 102), but this
effect was not confirmed by a second RNAi allele
(d5-HT2AJF02157 g = 0.07, p = 6.9 3 101) or
overexpression (d5-HT2ASceryUAS.cPa g = 0.21,
p = 0.28). Warm-treated controls underwent non-
statistical WAFO alterations.
(B) Knockdown of d5-HT2B with d5-HT2BKK111548
produced a decrease inWAFO (g =1.1, p = 6.83
1008) as did aMinos transposon insertion into the
gene: d-HT2BMB11858 (g =0.88, p = 4.13 1006).
(C) Orthologs of candidate mouse anxiety genes
were knocked down in the adult fly and tested for
WAFO changes. Four knockdowns produced
statistically significant reductions in WAFO:
tsrKK108706 (g = 0.89, p = 5.0 3 106);
tmodKK108701 (g = 0.81, p = 1.8 3 105);
CCKLR17D1KK108482 (g =0.45, p = 3.53 104);
and CCKLR17D3KK110484 (g = 0.40, p = 1.2 3
102). Sample sizes are indicated at the base of
the bars.
(D) Seventeen randomly selected orthologs’
knockdowns had trivial effects on WAFO.
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